护理学报 ›› 2022, Vol. 29 ›› Issue (16): 43-48.doi: 10.16460/j.issn1008-9969.2022.16.043
肿瘤相关静脉血栓栓塞症防治指南的质量评价及内容分析
褚玲玲a, 陈萍b, 冯丹b, 刘行b, 冯永冬b, 孙建国b
- 中国人民解放军陆军军医大学第二附属医院 a.护理处; b.肿瘤科,重庆 400037
摘要： 目的 对国内外肿瘤相关静脉相关性血栓栓塞症防治指南进行质量评价和内容分析,为临床进行基于证据转化的肿瘤相关静脉血栓栓塞症的防治提供理论依据,为构建本土化的护理实践指南提供参考。方法 系统检索国内外指南网、医学文献数据库及相关学会网站,运用AGREEⅡ指南评价工具对纳入指南进行质量评价,并对肿瘤相关静脉血栓栓塞症防治的各类推荐内容进行汇总分析。结果 本研究最终纳入14篇指南,13篇指南的质量评价结果为B级,1篇指南的质量评价结果为C级,13篇指南共提取血栓预防、风险评估、药物治疗、非药物干预、导管相关性血栓及其他类共6个方面的防治意见。结论 本研究整合肿瘤患者静脉血栓栓塞症防治领域较高质量的循证依据,为临床中的静脉血栓栓塞症的临床护理实践提供参考依据。
中图分类号:
- R473.73
| [1] 李拥军,孙艺红,门剑龙,等.医院内静脉血栓栓塞症防治与管理建议[J].中华医学杂志,2018,98(18):1383-1388. [2] Lyman GH, Culakova E,Poniewierski MS,et al.M Morbidity,Mortality and Costs Associated with Venous Thromboembolism in Hospitalized Patients with Cancer[J].Thromb Res,2018,164(suppl1):S112-S118.DOI:10.1016/j.thromres.2018.01.028. [3] Khorana AA, Francis CW, Culakova E, et al.Thromboembolism Is a Leading Cause of Death in Cancer Patients Receiving Outpatient Chemotherapy[J]. J Thromb Haemost,2007,5(3):632-634.DOI:10.1111/j.1538-7836.2007.02374.x. [4] 牛倩,江虹.肿瘤相关静脉血栓的监测进展[J].中华检验医学杂志,2016,39(10):739-742.DOI:10.3760/cma.j.issn.1009-9158.2016.10.003. [5] Khorana AA.Venous Thromboembolism and Prognosis in Cancer[J].Thrombosis Research,2010,125(6):490-493.DOI:10.1016/j.thromres.2009.12.023. [6] Heit JA, Spencer FA,White RH.The Epidemiology of Venous Thromboembolism[J].J Thromb Thrombolysis,2016,41(1):3-14.DOI:10.1007/s11239-015-1311-6. [7] Trinh VQ, Karakiewicz PI, Sammon J, et al.Venous Thromboembolism after Major Cancer Surgery:Temporal Trends and Patterns of Care[J].JAMA surgery,2014,149(1):43-49.DOI:10.1001/jamasurg.2013.3172. [8] Timp JF, Braekkan SK, Versteeg HH, et al.Epidemiology of Cancer-associated Venous Thrombosis[J]. Blood,2013,122(10):1712-1723.DOI:10.1182/BLOOD-2013-04-460121. [9] Posch F, Riedl J,Reitter EM,et al.Hypercoagulahilty,Venous Thromboembolism,and Death in Patients with Cancer. A Multi-state Model[J]. Thromh Haemosl,2016,115(4):817-826.DOI:10.1160/TH15-09-0758. [10] Kuderer NM,Culakova E,Lyman GH,et al.A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality[J]. Oncologist,2016,21(7):861-867.DOI:10.1634/theoncologist.2015-0361. [11] AGREE Enterprise. AGREEⅡinstrument[EB/OL].(2017-12-15)[2018-11-10].https://www.agreetrust.org/wp-content/uploads/2017/12/AGREE-Ⅱ-Users-Manual-and-23-item-Instrument-2009-Update-2017.pdf. [12] 朱政,胡雁,周英凤,等.推动证据临床转化(五)证据临床转化研究中的文献质量评价[J].2020,35(11):996-1000.DOI:10.16821/j.cnki.hsjx.2020.11.009. [13] Brouwers MC, Kho ME, Browman GP, et al.AGREEⅡ:Advancing Guideline Development,Reporting and Evaluation in Health Care[J].CMAJ,2010,182(18):E839-842.DOI:10.1503/cmaj.090449. [14] Brouwers MC, Kho ME, Browman GP,et al.AGREEⅡ:Advancing Guideline Development,Reporting and Evaluation in Health Care[J].CMAJ,2010,182(18):E839-E842.DOI:10.1503/cmaj.090449. [15] Guyatt G, Oxman AD, Akl EA,et al.GRADE Guidelines:1.Introduction-GRADE Evidence Profiles and Summary of Findings Tables[J].J Clin Epidemiol,2011,64(4):383-394. DOI:10.1016/j.jclinepi.2010.04.026. [16] 陈尹,胡世莲,李幼平,等.全球药物干预治疗单纯性高血压指南的系统评价[J].中国循证医学杂志, 2012, 12(10):1180-1194. [17] 乔舰. 组内相关系数的理论基础及建模应用[J].统计与信息论坛,2016,31(11):44-48. [18] Lyman GH, Carrier M, Ay C, et al.American Society of Hematology 2021 Guidelines for Management of Venous Thromboembolism: Prevention and Treatment in Patients with Cancer[J].Blood Adv, 2021, 5(4):927-974.DOI:10.1182/bloodadvances.2020003442. [19] Kakkos SK, Gohel M, Baekgaard N,et al.European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis[J]. Eur J Vasc Endovasc Surg, 2021, 61(1):9-82.DOI:10.1016/J.EJVS.2020.09.023. [20] Michael BS, Holmstrom B, Dana A,et al.Cancer-Associated Venous Thromboembolic Disease[EB/OL].(2020-04-26)[2020-12-25].https://www.nccn.org/professionals/Physician_gls/pdf/vte.pdf. [21] Rafii H,Frère C,Benzidia I,et al.Management of Cancer-related Thrombosis in the Era of Direct Oral Anticoagulants:A Comprehensive Review of the 2019 ITAC-CME Clinical Practice Guidelines.On behalf of the Groupe Francophone Thrombose et Cancer (GFTC)[J].J Med Vasc,2020,45(1):28-40.DOI:10.1016/j.jdmv.2019.12.004. [22] Venous Thromboembolic Diseases: Diagnosis,Management and Thrombophilia Testing[EB/OL].(2020-03-26)[2020-12-27].http://www.nice.org.uk/guidance/ng158. [23] Farge D,Frere C,Connors JM,et al.2019 International Clinical Practice Guidelines for the Treatment and Prophylaxis of Venous Thromboembolism in Patients with Cancer[J].Lancet Oncol,2019,20(10):e566-e581.DOI:10.1016/S1470-2045(19)30336-5. [24] 中国临床肿瘤学会肿瘤与血栓专家委员会.肿瘤相关静脉血栓栓塞症预防与治疗指南(2019版)[J].中国肿瘤临床, 2019, 46(13):653-660.DOI:10.3969/j.issn.1000-8179.2019.13.765. [25] Mandala M, Falanga A, Roila F. Management of Venous Thromboembolism (VTE) in Cancer Patients: ESMO Clinical Practice Guidelines[J].Ann Oncol,2011,22 (Supplement 6):vi85-vi92.DOI:10.1093/annonc/mdr392. [26] Watson HG, Keeling DM, Laffan M,et al.Guideline on Aspects of Cancer-related Venous Thrombosis[J].Br J Haematology,2015,170(5):640-648.DOI:10.1111/bjh.13556. [27] Zwicker JI, Connolly G,Carrier M,et al.Catheter-associated Deep Vein Thrombosis of the Upper Extremity in Cancer Patients:Guidance from the SSC of the ISTH[J]. J Thromb Haemost,2014,12(5):796-800.DOI:10.1111/jth.12527. [28] Kearon C, Akl EA, Ornelas J,et al.Antithrombotic Therapy for VTE Disease[J].CHEST,2016,149(2):315-352.DOI:10.1016/j.chest.2015.11.026. [29] 《中国血栓性疾病防治指南》专家委员会.中国血栓性疾病防治指南[J].中华医学杂志,2018,98(36):2861-2888.DOI:10.3760/cma.j.issn.0376-2491.2018.36.002. [30] Khorana AA, Otten HM,Zwicker JI,et al,Pabinger I.Prevention of Venous Thromboembolism in Cancer Outpatients: Guidance from the SSC of the ISTH[J].J Thromb Haemost,2014,12(11):1928-1931.DOI:10.1111/jth.12725. [31] Di Nisio M,Carrier M,Lyman GH,et al.Prevention of Venous Thromboembolism in Hospitalized Medical Cancer Patients: Guidance from the SSC of the ISTH[J].J Thromb Haemost,2014,12(10):1746-1749.DOI:10.1111/jth.12683. [32] 王一飞,何少茹.一个新的文献评价系统——GRADE评价系统[J].循证医学,2018,18(5):309-315.DOI:10.12019/j.issn.1671-5144.2018.05.013. |
| [1] | 杜玫洁, 张娜, 李咪琪, 黄素芳. 急危重症患者外周静脉通路建立相关指南的质量评价及内容分析[J]. 护理学报, 2022, 29(13): 39-45. |
| [2] | 张丽娟, 李金兰, 钟巧玲, 罗庆华, 张慧珍, 谢新华, 覃惠英. 癌症患者术后下肢淋巴水肿行综合消肿治疗联合泡沫颗粒绷带的效果观察[J]. 护理学报, 2021, 28(9): 62-65. |
| [3] | 尚苗苗, 王丽媛, 张振美, 颜丙萍, 刘莉, 杨丽娟. 成人患者气管切开护理相关临床实践指南的质量评价及内容分析[J]. 护理学报, 2021, 28(5): 38-42. |
| [4] | 龚德, 王颖敏, 钟丽容, 贾萌萌, 刘婷, 赵娟娟, 李琨. 神经源性膀胱功能障碍评估与管理相关指南的整合研究[J]. 护理学报, 2021, 28(3): 27-33. |
| [5] | 雷常彬, 刘珊珊, 蒋艳. 导管相关血流感染指南的质量评价及内容分析[J]. 护理学报, 2021, 28(23): 47-52. |
| [6] | 谢方瑜, 孙秀杰, 芦秀燕, 王佳弘, 梁涛. 低质量证据强推荐意见在中国护理实践指南中的现状分析[J]. 护理学报, 2021, 28(20): 39-43. |
| [7] | 鲍丽超, 韩慧, 邹晓月. 基于AGREE II造口旁疝护理预防与管理的指南评价[J]. 护理学报, 2021, 28(19): 48-51. |
| [8] | 蔡莹莹, 张俊峰, 郑可欣, 张兰芳, 余璐萍, 曾文, 陈梦云, 黄琼珊. 老年肿瘤患者跌倒评估及管理最佳证据总结[J]. 护理学报, 2021, 28(18): 22-27. |
| [9] | 陈玉华, 张兵, 谢娟, 唐荣荣. 2020年ICFSR共识指南解读及对我国预防和管理老年人衰弱的启示[J]. 护理学报, 2021, 28(15): 69-73. |
| [10] | 刘杨, 罗健, 朱佩佩, 周兴婷, 刘苗, 王丽媛, 李卓颖, 朱晓敏. 髋部手术患者术后康复指南的质量评价及内容分析[J]. 护理学报, 2021, 28(12): 56-61. |
| [11] | 徐玉林, 张春秀. 慢性肾脏病患者妊娠管理相关指南的质量评价及内容分析[J]. 护理学报, 2021, 28(11): 56-61. |
| [12] | 周芬. 患者及公众参与临床实践指南构建及其方法的研究进展[J]. 护理学报, 2020, 27(5): 14-17. |
| [13] | 黄琼珊, 陈曼华, 蔡莹莹, 杨素敏, 李怡君, 林淳. 可视化“护士指南针”交接班制度在神经外科的应用[J]. 护理学报, 2020, 27(4): 11-15. |
| [14] | 赵存, 王兴蕾, 韩春彦, 裴菊红, 张亚斌, 苟玲, 豆欣蔓. 全髋关节置换患者疼痛评估循证指南质量评价[J]. 护理学报, 2020, 27(24): 31-37. |
| [15] | 程迪, 胡德英, 郭潇, 代艺, 孙丽. 巴林特小组对经历患者自杀事件护士焦虑抑郁及自我效能感的影响[J]. 护理学报, 2020, 27(15): 69-73. |
|